OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Warner & Kaine Applaud $35 Monthly Insulin Caps by Largest Insulin Manufacturers Following Inflation Reduction Act Implementation

Press Release

Date: Jan. 2, 2024
Location: Washington, D.C.
Issues: Health Insurance Health and Health Care

BREAK IN TRANSCRIPT

"When we capped insulin at $35 a month for Medicare patients as part of the Inflation Reduction Act, we put pressure on big pharmaceutical companies to do the same, and we are seeing the impact. As we start the New Year, millions of Americans are will pay less for the medication they need. As we move into 2024, the Senate Finance Committee will keep working on measures to lower drug prices and improve transparency for all Americans."

BREAK IN TRANSCRIPT


Source
arrow_upward